These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 30277860)
21. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes. Ingegnoli F; Carmona L; Castrejon I Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740 [TBL] [Abstract][Full Text] [Related]
22. [Contemporaneous clinical picture of systemic sclerosis]. Wiesik-Szewczyk E; Olesińska M Pol Merkur Lekarski; 2010 May; 28(167):416-20. PubMed ID: 20568410 [TBL] [Abstract][Full Text] [Related]
23. Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis. Hisada S; Takeuchi S; Tozawa T; Yamada Y; Ito Y; Kodera M J Dermatol; 2024 Oct; 51(10):1329-1334. PubMed ID: 38963343 [TBL] [Abstract][Full Text] [Related]
24. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Wirz EG; Jaeger VK; Allanore Y; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Tikly M; Vettori S; Balbir Gurman A; Damjanov N; Müller-Ladner U; Distler J; Li M; Häusermann P; Walker UA; Ann Rheum Dis; 2016 Jul; 75(7):1285-92. PubMed ID: 26232495 [TBL] [Abstract][Full Text] [Related]
25. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome. Wannarong T; Muangchan C Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672 [TBL] [Abstract][Full Text] [Related]
26. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341 [TBL] [Abstract][Full Text] [Related]
27. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785 [TBL] [Abstract][Full Text] [Related]
28. Anti-collagen type v: a marker of early systemic sclerosis? Ugolini-Lopes MR; Mantovani E; Bonoldi VLN; de Medeiros Ribeiro AC; Bonfá E; Yoshinari N; Andrade D Adv Rheumatol; 2019 May; 59(1):19. PubMed ID: 31088556 [TBL] [Abstract][Full Text] [Related]
29. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450 [TBL] [Abstract][Full Text] [Related]
30. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. Lescoat A; Huang S; Carreira PE; Siegert E; de Vries-Bouwstra J; Distler JHW; Smith V; Del Galdo F; Anic B; Damjanov N; Rednic S; Ribi C; Bancel DF; Hoffmann-Vold AM; Gabrielli A; Distler O; Khanna D; Allanore Y; JAMA Dermatol; 2023 Aug; 159(8):837-847. PubMed ID: 37378994 [TBL] [Abstract][Full Text] [Related]
33. Systemic sclerosis in Argentina: evaluation of a large cohort from a single centre and comparison with other international series. Scolnik M; Lancioni E; Saucedo C; Marin J; Sabelli M; Bedran Z; Soriano ER; Catoggio LJ Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-94-7. PubMed ID: 25198424 [TBL] [Abstract][Full Text] [Related]
34. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort. Trapiella-Martínez L; Díaz-López JB; Caminal-Montero L; Tolosa-Vilella C; Guillén-Del Castillo A; Colunga-Argüelles D; Rubio-Rivas M; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Chamorro-Fernández AJ; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñóz M; Fonollosa-Pla V; Simeón-Aznar CP; Autoimmun Rev; 2017 Aug; 16(8):796-802. PubMed ID: 28564618 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672 [TBL] [Abstract][Full Text] [Related]
36. Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor. Yu Q; Zhang J; Fan L; Yu T; Liu B; Ding J Discov Med; 2023 Apr; 35(175):193-200. PubMed ID: 37105929 [TBL] [Abstract][Full Text] [Related]
37. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases. Dave J; Mahajan S; Khadilkar P; Pradhan V J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940 [TBL] [Abstract][Full Text] [Related]
38. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M; Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617 [TBL] [Abstract][Full Text] [Related]
39. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study. Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519 [No Abstract] [Full Text] [Related]
40. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis. Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]